Latest Market Share News

Page 2 of 113
Orica delivered its highest earnings in more than 15 years, lifting FY2026 EBIT 7% to A$1.06 billion and increasing its unfranked dividend 12% to 64 cents a share. Strong growth from Digital Solutions and Specialty Mining Chemicals helped offset currency pressure, litigation costs and a softer Indonesian coal market.
Victor Sage
Victor Sage
12 Nov 2026
Mainfreight has delivered a sharp first-half recovery, with net profit rising 66.4% to NZ$155.4 million as freight volumes, customer gains and overseas operations improved. The NZX-listed logistics group also approved an 85-cent interim dividend, while warning that margins and economic conditions remain uneven.
Victor Sage
Victor Sage
12 Nov 2026
PEXA has sharply lowered its FY27 revenue and profit expectations after Australian Exchange volumes fell 11.5% in the first quarter. Stable market share and customer satisfaction offer some support, but October transfer volumes were down 26% and a regulatory pricing decision remains pending.
Victor Sage
Victor Sage
11 Nov 2026
Propel Funeral Partners says its acquisition engine remains funded after resilient first-quarter trading offset a temporary contraction in industry death volumes. Revenue and Operating EBITDA were each broadly flat year on year, while constant-currency growth was approximately 3%.
Victor Sage
Victor Sage
9 Nov 2026
ANZ Group Holdings reported a 31% rise in FY26 cash profit to A$7.591 billion, helped by sharp cost reductions and stronger Australian banking performance. The 83-cent final dividend was maintained, but rising impairments, weaker New Zealand earnings and heavier capital demands leave the next phase of the turnaround less straightforward.
Victor Sage
Victor Sage
9 Nov 2026
The Colonial Motor Company delivered a stronger FY2026 result, but warned that first-quarter earnings have come under pressure as Chinese vehicle brands and new energy vehicles reshape New Zealand’s automotive market. The company is responding with BYD and JAC investments while preserving its conservative balance sheet.
Victor Sage
Victor Sage
6 Nov 2026
Monster Beverage delivered a strong third quarter, with sales rising 16.7% to US$2.56 billion and international revenue climbing 28.1%. The trade-off was narrower margins as aluminium, freight, fuel, marketing and transformation costs increased.
Victor Sage
Victor Sage
6 Nov 2026
James Hardie delivered a sharp rebound in second-quarter profitability, with continuing-operations sales up 24% and adjusted EBITDA up 44%. The building products group reaffirmed its FY27 earnings guidance, lifted its free cash flow target above US$650 million and accelerated debt reduction.
Victor Sage
Victor Sage
6 Nov 2026
Edwards Lifesciences delivered stronger-than-expected third-quarter growth and lifted its full-year 2026 outlook, led by a sharp rise in mitral and tricuspid therapies. A US$220.2 million impairment charge remains a notable counterpoint to the upbeat operating performance.
Ada Torres
Ada Torres
5 Nov 2026
COG Financial Services has opened FY2027 with a sharp earnings increase, driven by a major acceleration in salary packaging and novated leasing. The company is targeting EBITDA to shareholders growth of 10% or better for the full year, although the quarterly figures remain unaudited and acquisition effects complicate comparisons.
Claire Turing
Claire Turing
4 Nov 2026
Henry Schein has raised its 2026 adjusted earnings and EBITDA outlook after a quarter of stronger sales, led by US dental merchandise volumes. The result also included a tariff refund benefit, making the quality of earnings an important part of the story.
Ada Torres
Ada Torres
4 Nov 2026
Nexsen has secured ISO 13485 certification covering the design, development and manufacture of its StrepSure Group B Streptococcus diagnostic. The milestone strengthens the product’s regulatory and manufacturing platform, but does not yet amount to FDA or TGA approval.
Ada Torres
Ada Torres
2 Nov 2026

Browse the archive

Full archive